Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-19-038141
Filing Date
2019-02-13
Accepted
2019-02-13 16:44:03
Documents
2
Group Members
COLUMN GROUP II GP, LPDAVID V. GOEDDELPETER SVENNILSONPONOI CAPITAL, LPPONOI MANAGEMENT, LLCTIM KUTZKEY

Document Format Files

Seq Description Document Type Size
1 SC 13G d670441dsc13g.htm SC 13G 129704
2 EX-99.1 d670441dex991.htm EX-99.1 9391
  Complete submission text file 0001193125-19-038141.txt   140764
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP II, LP (Filed by) CIK: 0001600420 (see all company filings)

IRS No.: 211417046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 650-489-9000
Arcus Biosciences, Inc. (Subject) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90423 | Film No.: 19598105
SIC: 2834 Pharmaceutical Preparations